0001062993-11-001099.txt : 20110322 0001062993-11-001099.hdr.sgml : 20110322 20110322170124 ACCESSION NUMBER: 0001062993-11-001099 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100608 FILED AS OF DATE: 20110322 DATE AS OF CHANGE: 20110322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gitman Paul CENTRAL INDEX KEY: 0001375378 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 11704463 MAIL ADDRESS: STREET 1: 167 EXECUTIVE DRIVE CITY: MANHASSET HILLS STATE: NY ZIP: 11040 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4/A 1 form4a.xml AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0303 4/A 2010-06-08 2010-06-10 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001375378 Gitman Paul 167 EXECUTIVE DRIVE MANHASSET HILLS NY 11040 1 0 0 0 Common Stock 2010-06-08 4 M 0 5425 1.00 A 41425 D Stock Option (Right to Buy) 1.00 2010-06-08 4 M 0 5425 0 D 2002-09-30 2012-09-29 Common Stock, $.001 par value 5425 159000 D This item has been revised from "5,452" to "5,425" to reflect the correct amount of securities acquired. This item has been revised from "41,452" to "41,425" to reflect the correct amount of securities beneficially owned following the reported transaction. This item has been revised from "5,452" to "5,425" to reflect the correct amount of options exercised. This item has been revised from "158,973" to "159,000" to reflect the correct number of derivative securities beneficially owned following the reported transaction. This amendment to the Form 4 previously filed on June 10, 2010 is being filed solely to correct typographical errors set forth in Tables I and II as described above. /s/ Paul Gitman by Carl A. Valenstein, attorney in fact 2011-03-22